BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11754874)

  • 1. Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum.
    Parent MB; Master S; Kashlub S; Baker GB
    Biochem Pharmacol; 2002 Jan; 63(1):57-64. PubMed ID: 11754874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain.
    Tanay VA; Parent MB; Wong JT; Paslawski T; Martin IL; Baker GB
    Cell Mol Neurobiol; 2001 Aug; 21(4):325-39. PubMed ID: 11775064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Task-dependent effects of the antidepressant/antipanic drug phenelzine on memory.
    Parent MB; Habib MK; Baker GB
    Psychopharmacology (Berl); 1999 Mar; 142(3):280-8. PubMed ID: 10208320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.
    Parent MB; Habib MK; Baker GB
    Biochem Pharmacol; 2000 May; 59(10):1253-63. PubMed ID: 10736426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.
    Todd KG; Baker GB
    J Pharm Pharm Sci; 2008 May; 11(2):14s-21s. PubMed ID: 19203467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
    Todd KG; Baker GB
    J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic function.
    McKenna KF; McManus DJ; Baker GB; Coutts RT
    J Neural Transm Suppl; 1994; 41():115-22. PubMed ID: 7931216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.
    Matveychuk D; MacKenzie EM; Kumpula D; Song MS; Holt A; Kar S; Todd KG; Wood PL; Baker GB
    Cell Mol Neurobiol; 2022 Jan; 42(1):225-242. PubMed ID: 33839994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain.
    Paslawski TM; Sloley BD; Baker GB
    Prog Brain Res; 1995; 106():181-6. PubMed ID: 8584653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats.
    See RE; Chapman MA; Klitenick MA
    Brain Res; 1992 Aug; 588(1):177-80. PubMed ID: 1356587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain.
    McManus DJ; Baker GB; Martin IL; Greenshaw AJ; McKenna KF
    Biochem Pharmacol; 1992 Jun; 43(11):2486-9. PubMed ID: 1610412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.
    MacKenzie EM; Grant SL; Baker GB; Wood PL
    Neurochem Res; 2008 Mar; 33(3):430-6. PubMed ID: 17768678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antidepressant phenelzine enhances memory in the double Y-maze and increases GABA levels in the hippocampus and frontal cortex of rats.
    Simpson SM; Hickey AJ; Baker GB; Reynolds JN; Beninger RJ
    Pharmacol Biochem Behav; 2012 Jul; 102(1):109-17. PubMed ID: 22503968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.
    Paslawski T; Treit D; Baker GB; George M; Coutts RT
    Psychopharmacology (Berl); 1996 Sep; 127(1):19-24. PubMed ID: 8880939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
    McKenna KF; Baker GB; Coutts RT; Greenshaw AJ
    J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of Neurotransmitter Levels Has Differential Effects on Formalin-Evoked Nociceptive Behavior in Male and Female Mice.
    Mifflin KA; Benson C; Thorburn KC; Baker GB; Kerr BJ
    J Pain; 2016 Apr; 17(4):483-98. PubMed ID: 26748043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine.
    Matveychuk D; Nunes E; Ullah N; Velázquez-Martinez CA; MacKenzie EM; Baker GB
    J Neural Transm (Vienna); 2013 Jun; 120(6):987-96. PubMed ID: 23392617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive Effects of the Antidepressant Phenelzine are Mediated by Context-Dependent Inhibition of Neuronal Responses in the Dorsal Horn.
    Potter LE; Doolen S; Mifflin K; Tenorio G; Baker G; Taylor BK; Kerr BJ
    Neuroscience; 2018 Jul; 383():205-215. PubMed ID: 29752984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA).
    Baker GB; Wong JT; Yeung JM; Coutts RT
    J Affect Disord; 1991 Mar; 21(3):207-11. PubMed ID: 1648582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evidence for reduced cortical glutamate-glutamine cycling in rats treated with the antidepressant/antipanic drug phenelzine.
    Yang J; Shen J
    Neuroscience; 2005; 135(3):927-37. PubMed ID: 16154287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.